First Deputy Kharkiv Mayor Ihor Terekhov and Head of Representative Office of Hyundai Corporation in Ukraine Jeong Ilryoung have discussed a possibility of the company’s participation in some infrastructure projects being implemented in the city, in particular, in a tender to build subway and procurement of rolling stock for subway. “Our company has extensive experience in such projects in different countries, including those that used the same subway characteristics as in Kharkiv. We do turnkey work. We install our system and rolling stock. We work with the government of South Korea, therefore, would like to continue our cooperation at the government level in financing other urban projects,” the press service of the Kharkiv City Council reported, citing Jeong Ilryoung.
Terekhov said that Kharkiv provides absolutely equal conditions for all bidders and is interested in cooperation if Hyundai Corporation wins the tender.
He also said that, according to the technical conditions of the tender for procurement of rolling stock, it should be a new generation of energy-saving trains equipped with asynchronous engines.
In addition, the first deputy mayor of Kharkiv and the head of the Hyundai Corporation in Ukraine discussed possible cooperation in the development of ground-based urban electric transport.
“We discussed the possibility of attracting grant money from the Korean government to maintain rolling stock with the subsequent development of a project to upgrade the tram fleet. However, I will emphasize that this should be a comprehensive solution – we need not only to buy new trains, but we also need to update the tram tracks. For example, first, you need to repair certain routes, and after that put new trams on them,” Terekhov said.
The book of records of Ukraine has declared Corvalol medicine made by PJSC Farmak (Kyiv) the most famous sedative on the country’s market. Head of the supervisory board of the company Filia Zhebrovska said at the award ceremony said that Corvalol, developed in 1959 by scientists of Lomonosov Kyiv Chemical and Pharmaceutical Plant, and Farmak has been a legal successor of it since 1991, is being produced at Farmak in line with all European standards.
She said that Farmak produces Corvalol in a closed cycle from the synthesis of a substance to the production of finished dosage forms and guarantees its quality at every stage of production.
In turn, Executive Director Volodymyr Kostiuk said that with the development of pharmaceutical manufacturing technology, Farmak will also improve the production technology of Corvalol and expand the line of ready-made forms of the drug. In particular, at present the drug is marketed in the form of drops, tablets and soft capsules.
“By our example, we will show that modern pharmaceutical production exists in Ukraine. Even the old Soviet Corvalol today is not the same as it was 60 years ago. Now it is produced using modern equipment, manufactured according to all standards of Ukraine, Europe and the United States. Unfortunately, I cannot say this about our rivals, who do not care about quality but occupy the market. I hope the situation will improve in the near future,” he said.
Currently, Farmak has a number of drugs, the production of which in a closed cycle was started by the Lomonosov Kyiv Chemical and Pharmaceutical Plant, in particular, Diazolin, Corvalol, Naphthyzin and Validol.
In general, the company has more than 220 product dossiers, produces about 20 new drugs annually.
The decision to develop technology and create a cardiovascular medicine, similar to Valocordin, which was produced in Germany, at the Lomonosov Kyiv Chemical and Pharmaceutical Plant was made in 1959. The first batch of the drug was released as early as next year at the same enterprise. At that time, it was a know-how – a generic European sedative drug.
Farmak since 1991 is the only manufacturer of Corvalol on the post-Soviet territory. The Corvalol trademark is protected in 15 countries of Europe and Middle Asia, including Germany, Armenia, Georgia, Azerbaijan, Tajikistan, Kyrgyzstan and Kazakhstan.
The number of Green Card international insurance contracts signed by the member companies of the Motor (Transport) Insurance Bureau of Ukraine (MTIBU) in January 2019 increased by 12.79% compared to January 2018, to 61,104.
According to the website of the MTIBU, the amount of accrued insurance premiums for January 2019 rose by 14.55% compared to the same month last year, to UAH 147.164 million.
At the same time, the amount of claim fee payments decreased by 55.15%, to EUR417,036.
The number of paid claims was down by 48.37%, to 222.
Exports of agricultural products from Ukraine in January 2019 amounted to $1.7 billion, which is almost 22.5% more than in the same month in 2018, the press service of the Ministry of Agrarian Policy and Food has reported.
According to the report, grain crops traditionally remain the leaders of Ukrainian agricultural exports with a share of 44.6% in the total structure of agricultural exports, the share of vegetable oils is 19.8%, oilseeds some 9.7%.
“The EU countries rank first among our sales markets, to which we exported $668 million worth of products in January. Asian countries lost to our European neighbors with a little more than $641 million. African countries rank third. Ukrainian agricultural exports there stood at $292.2 million,” Acting Minister of Agrarian Policy and Food Olha Trofimtseva said.
According to her, the top five key countries importing Ukrainian agricultural products in January (by volume of exports in value terms) were Egypt with $153.6 million, the Netherlands with $149.9 million, India with $143.9 million, Spain with $135.8 million, and Turkey with $112.3 million.